This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waites, K. B. Articles by Schelonka, R. L. Search for Related Content PubMed PubMed Citation Articles by Waites, K. B. Articles by Schelonka, R. L.

Mycoplasmas and Ureaplasmas as Neonatal Pathogens

Departments of Pathology,¹ Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama 35249²

The genital mycoplasmas represent a complex and unique group of microorganisms that have been associated with a wide array of infectious diseases in adults and infants. The lack of conclusive knowledge regarding the pathogenic potential of Mycoplasma and Ureaplasma spp. in many conditions is due to a general unfamiliarity of physicians and microbiology laboratories with their fastidious growth requirements, leading to difficulty in their detection; their high prevalence in healthy persons; the poor design of research studies attempting to base association with disease on the mere presence of the organisms in the lower urogenital tract; the failure to consider multifactorial aspects of diseases; and considering these genital mycoplasmas only as a last resort. The situation is now changing because of a greater appreciation of the genital mycoplasmas as perinatal pathogens and improvements in laboratory detection, particularly with regard to the development of powerful molecular nucleic acid amplification tests. This review summarizes the epidemiology of genital mycoplasmas as causes of neonatal infections and premature birth; evidence linking ureaplasmas with bronchopulmonary dysplasia; recent changes in the taxonomy of the genus Ureaplasma; the neonatal host response to mycoplasma and ureaplasma infections; advances in laboratory detection, including molecular methods; and therapeutic considerations for treatment of systemic diseases.

This article has been cited by other articles:

• Geissdorfer, W., Sandner, G., John, S., Gessner, A., Schoerner, C., Schroppel, K. (2008). Ureaplasma urealyticum Meningitis in an Adult Patient. J. Clin. Microbiol. 46: 1141-1143 [Abstract] [Full Text]  
• Degrange, S., Renaudin, H., Charron, A., Bebear, C., Bebear, C. M. (2008). Tetracycline Resistance in Ureaplasma spp. and Mycoplasma hominis: Prevalence in Bordeaux, France, from 1999 to 2002 and Description of Two tet(M)-Positive Isolates of M. hominis Susceptible to Tetracyclines. Antimicrob. Agents Chemother. 52: 742-744 [Abstract] [Full Text]  
• Zeugswetter, F., Weissenbock, H., Shibly, S., Hassan, J., Spergser, J. (2007). Lethal bronchopneumonia caused by Mycoplasma cynos in a litter of golden retriever puppies. Vet Rec. 161: 626-627 [Full Text]  
• Duffy, L., Glass, J., Hall, G., Avery, R., Rackley, R., Peterson, S., Waites, K. (2006). Fluoroquinolone Resistance in Ureaplasma parvum in the United States. J. Clin. Microbiol. 44: 1590-1591 [Abstract] [Full Text]